Results 361 to 370 of about 2,114,452 (380)
Some of the next articles are maybe not open access.

Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.

New England Journal of Medicine, 2023
BACKGROUND Respiratory syncytial virus (RSV) infection causes considerable illness in older adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein-based (RSVpreF) vaccine in this population are unknown.
E. Walsh   +30 more
semanticscholar   +1 more source

Vaccines, vaccination in Brucellosis

Annales de l'Institut Pasteur / Microbiologie, 1987
International ...
Plommet, Michel   +2 more
openaire   +4 more sources

Vaccines and Vaccination

New England Journal of Medicine, 2001
More than 70 bacteria, viruses, parasites, and fungi are serious human pathogens.1 Vaccines are available against some of these agents and are being developed against almost all the other bacteria and viruses and about half of the parasites. Table 1 lists infections for which there are now licensed vaccines and those for which a candidate vaccine has ...
openaire   +3 more sources

Footrot vaccines and vaccination

Vaccine, 2014
Research on footrot in small ruminants, which is caused by Dichelobacter nodosus, has led to development of vaccines and their application for control, treatment and eradication of the disease in sheep. Footrot vaccines have evolved over decades to contain monovalent whole cell, multivalent recombinant fimbrial, and finally mono or bivalent recombinant
Om P. Dhungyel   +2 more
openaire   +3 more sources

Vaccines

Current Opinion in Immunology, 1990
Much progress has been made towards reaching an understanding of immune responses at the molecular level. This has provided much needed information for identifying the antigens which will afford protection against diseases such as rabies, malaria, whooping cough, hepatitis and acquired immune deficiency syndrome, and for presenting them to the immune ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy